Myoinositol for the Treatment of Ovarian and Psychiatric Disorder in Polycystic Ovary Syndrome (PCOS) Patients

Clinical Trial ID NCT01246310

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01246310

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med 2010 2.21
2 Insulin and hyperandrogenism in women with polycystic ovary syndrome. J Steroid Biochem Mol Biol 2009 1.14
3 Risk of depression and other mental health disorders in women with polycystic ovary syndrome: a longitudinal study. Fertil Steril 2008 1.07
4 Double-blind, controlled trial of inositol treatment of depression. Am J Psychiatry 1995 0.95
5 Metabolic and hormonal effects of myo-inositol in women with polycystic ovary syndrome: a double-blind trial. Eur Rev Med Pharmacol Sci 2009 0.95
6 Contribution of myo-inositol to reproduction. Eur J Obstet Gynecol Reprod Biol 2009 0.91
Next 100